Esophagin Antibodies

Santa Cruz Biotechnology features a diverse variety of Esophagin monoclonal antibodies for investigating esophagin in various biological processes. Esophagin monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Esophagin, primarily expressed in the esophagus, plays a crucial role in maintaining the structural integrity and function of the epithelial barrier. The involvement of esophagin in cellular adhesion and signaling pathways makes it significant in studies related to esophageal health and disease. Research focusing on esophagin has become increasingly important for understanding conditions such as gastroesophageal reflux disease (GERD) and esophageal cancer. Investigating esophagin function can provide insights into therapeutic targets and potential interventions for esophageal disorders. Current research continues to uncover new roles for esophagin in maintaining esophageal tissue homeostasis. Ongoing studies are revealing additional functions of esophagin in cellular processes and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of esophagin's role in health and disease, contributing to potential therapeutic breakthroughs in esophageal disorders.